Punit Dhillon   Punit is also the co-founder and CEO of OncoSec Medical, Inc. a biopharmaceutical company developing its advanced-stage immunotherapy to treat solid tumors. Punit was formerly Vice President of Finance and Operations at Inovio Pharmaceuticals, Inc. In his management experience, Punit has raised over $160 million through multiple financings and several licensing deals including early stage deals with Merck and Wyeth. More recently, Punit has been leading the development of a pipeline of novel immunotherapy candidates for a wide range of solid tumor applications at OncoSec with an industry leading technology. Punit’s management experience spans corporate finance, M&amp;A, integration, successful in-licensing of key intellectual property, strategy implementation, corporate transactions and collaborations with leading Universities and working with several key opinion leaders across the globe. As a serial entrepreneur, Mr. Dhillon places great value on helping future leaders overcome challenges through mentorship and education. Mr. Dhillon is an active member in his community focused on promoting an active lifestyle and grass roots community involvement, including scholarships to support students pursuing post-secondary education. He is also the founder of becancerpositive.org a community dedicated to sharing and connecting; highlighting stories from around the globe and creating a platform where people can share with others their own unique experiences with cancer and help people find their own silver lining. In 2013, he was recognized as the "Top 100" CEOs by PharmaVoice and "Most Admired CEO" by the San Diego Business Journal. In 2014, he was recognized as a finalist for Ernst &amp; Young’s "Entrepreneur of the Year." Punit holds a Bachelor of Arts with honors in Political Science and a minor in Business Administration from Simon Fraser University.